Free provider profile

MOHAMAD KASSAR, M.D.

NPI 1063691830
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MOHAMAD KASSAR?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MOHAMAD KASSAR prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Revlimid
  • Calquence
  • Lenalidomide
  • Pomalyst
  • Ibrance

See all hematologist-oncologists in IN who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

219-924-8178

Fax

219-924-8179

Practice address

1001 CALUMET AVE, DYER, IN, 46311

Registry updated
2021-03-22
NPI issued
2007-10-30
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

1001 CALUMET AVE, DYER, IN, 46311

219-924-8178

Single practice location

Enumerated 2007-10-30

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 5 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,464

Medicare patients

378

Part D drug cost

$5,668,876

Brand-name share

Not published

of this prescriber's Part D claims

DrugClaimsMedicare cost
Revlimid (Lenalidomide)82$1,503,255
Calquence (Acalabrutinib Maleate)64$923,606
Pomalyst (Pomalidomide)23$439,143
Lenvima (Lenvatinib Mesylate)17$388,773
Lenalidomide (Lenalidomide)30$380,124
Ibrance (Palbociclib)22$323,797
Jakafi (Ruxolitinib Phosphate)12$210,876
Brukinsa (Zanubrutinib)15$205,319

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across IN — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.